Skip to main content
Rural Health Information Hub

Rural Health
News by Topic: Pharmacy and prescription drugs

Nov 20, 2026 - Notice from the Centers for Medicare & Medicaid Services (CMS) making corrections to the November 13, 2026, notice.
Source: Federal Register
Nov 13, 2026 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on the following information collections: 1) Survey of Retail Prices and 2) Basic Health Program (BHP) Supporting Regulations. Comments are due by December 14, 2026.
Source: Federal Register
Nov 13, 2026 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on the following information collections: 1) Electronic Funds Transfer Authorization Agreement and 2) Rebate Reduction Requests under Sections 11101 and 11102 of the Inflation Reduction Act (IRA). Comments are due by December 14, 2026.
Source: Federal Register
Nov 9, 2026 - Notice of a final rule from the Centers for Medicare & Medicaid Services (CMS) addressing: 1) changes to the Physician Fee Schedule and Medicare Part B payment policies; 2) policies for the Medicare Prescription Drug Inflation Rebate Program under the Inflation Reduction Act of 2022; 3) limiting Medicare coverage of certain individuals; 4) the Ambulatory Specialty Model; 5) updates to drugs and biological products paid under Part B; 6) Medicare Shared Savings Program requirements; 7) updates to the Quality Payment Program; 8) updates to policies for Rural Health Clinics (RHCs) and Federally Qualified Health Centers (FQHCs); 9) updates to the Ambulance Fee Schedule regulations; 10) codification of the Inflation Reduction Act and Consolidated Appropriations Act, 2026 provisions; 11) updates to Clinical Laboratory Fee Schedule regulations; and 12) updates to the Medicare Promoting Interoperability Program. These regulations are effective January 1, 2027.
Source: Federal Register
Nov 9, 2026 - Notice of a final rule from the Centers for Medicare & Medicaid Services (CMS) that codifies the Medicare Drug Price Negotiation Program, establishes certain new policies for the Negotiation Program and the Medicare Prescription Drug Benefit Program as required by the Inflation Reduction Act of 2022, and finalizes a proposed modification to the fixed combination drug policy. These regulations are effective December 5, 2026, and are applicable to the Negotiation Program with respect to initial price applicability year 2029 and to Part D Program coverage beginning January 1, 2029.
Source: Federal Register
Nov 9, 2026 - Notice from the Centers for Medicare & Medicaid Services (CMS) making typographical corrections to the October 20, 2026, proposed rule.
Source: Federal Register
Nov 5, 2026 - Notice from the Centers for Medicare & Medicaid Services (CMS) seeking comments on the following information collections: 1) Collection Requirements for Compendia for Determination of Medically-accepted Indications for Off-label Uses of Drugs and Biologicals in an Anti-cancer Chemotherapeutic Regimen; 2) Quality Bonus Payment Appeals; and 3) The In-Center Hemodialysis Consumer Assessment of Healthcare Providers and Systems Survey Mode Experiment. Comments are due by December 7, 2026.
Source: Federal Register
Oct 20, 2026 - Notice of a proposed rule that would implement the following sections of the Consolidated Appropriations Act, 2026: 1) section 6219, "Adjustments to Medicare Part D Cost-Sharing Reductions for Low-Income Individuals;" 2) section 6220, "Requiring Enhanced and Accurate Lists of (REAL) Health Providers Act;" and 3) section 6224, "Modernizing and Ensuring Pharmacy Benefit Manager Accountability." The implementation of Section 6219 would reduce the generic drug copayment from $1 to $0 for full-benefit dual eligible individuals at or below 100% of the Federal Poverty Level, effective for plan years starting January 1, 2028. The implementation of Section 6220, the REAL Health Providers Act, would establish new provider directory accuracy and accountability requirements for Medicare Advantage (MA) organizations beginning in contract year 2028. In addition, CMS has several proposals to implement section 6224, which established requirements related to pharmacy benefit managers (PBMs) and their affiliates specific to the Medicare Part D program. Comments are due by December 15, 2026.
Source: Federal Register
Oct 2, 2026 - Notice of final rule from the Centers for Medicare & Medicaid Services (CMS) implementing the Global Benchmark for Efficient Drug Pricing Model (GLOBE Model), a new Medicare payment model under section 1115A of the Social Security Act. The GLOBE Model would test whether a payment model that uses an alternative method for calculating Part B inflation rebate amounts for certain separately payable Part B drugs and biological products reduces costs for Original Medicare fee-for-service (FFS) beneficiaries and the Medicare program while preserving quality of care. This rule also summarizes and responds to comments received on the December 23, 2025, proposed rule, including the potential impact of this model on small rural hospitals. These regulations are effective November 30, 2026.
Source: Federal Register
Sep 30, 2026 - Offers an interview with an Appalachian pharmacy educator discussing access to pharmacies for rural communities. Discusses policy, rural culture, barriers in healthcare access, trust, and rural innovation.
Source: Drug Topics